Gilead Sciences Quad Study 102 Results Conference Call on Wednesday, March 7, 2012

Conference Call and Webcast to Follow

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mar 6, 2012 - Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the Quad Study 102 results will be presented on a conference call on Wednesday, March 7, at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. The conference call and slides will be accessible via the internet from the company's website.

To access the webcast link, log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 1-866-788-0541 (U.S.) or 1-857-350-1679 (international) and dial the participant passcode 57882166 to access the call. Telephone replay will be available approximately two hours after the call through 11:59 p.m. Eastern Time, March 10, 2012. To access the replay, please call 1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the participant passcode 14598403. The webcast will be archived on www.gilead.com for 14 days following the call.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

 

Contact: Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715
Investor Relations

 

 

Posted: March 2012

View comments

Hide
(web1)